SCHEMBL23647966

SCHEMBL23647966

Cc1c(Br)cnc2c1-n1c(C)nnc1C(C)(C)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29968867 1.00 — —
SCHEMBL23648267 0.76 — —
SCHEMBL30005652 0.74 — —
SCHEMBL30668484 0.74 — —
SCHEMBL23658702 0.72 — —
SCHEMBL23647908 0.72 — —
SCHEMBL30006156 0.72 — —
SCHEMBL23647899 0.72 — —
SCHEMBL30006228 0.72 — —
SCHEMBL23648190 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4090661-B1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR GRUENENTHAL GMBH (DE) 2025-03-12 — — EP disclosed
US-20220372041-A1 QUINOXALINE DERIVATIVES GRUENENTHAL GMBH (DE) 2022-11-24 — — US disclosed
EP-4090661-A1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR Grünenthal GmbH (DE) 2022-11-23 — — EP disclosed
WO-2021144440-A1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR Grünenthal GmbH (DE) 2021-07-22 — — WO disclosed
WO-2021144440-A1 QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR Grünenthal GmbH (DE) 2021-07-22 — — WO disclosed
Send feedback